- Home
- FSS vs IONS Comparison
FSS vs IONS Comparison
Compare FSS & IONS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSS
- IONS
- Stock Information
- Founded
- FSS 1901
- IONS 1989
- Country
- FSS United States
- IONS United States
- Employees
- FSS N/A
- IONS N/A
- Industry
- FSS Auto Manufacturing
- IONS Biotechnology: Pharmaceutical Preparations
- Sector
- FSS Consumer Discretionary
- IONS Health Care
- Exchange
- FSS Nasdaq
- IONS Nasdaq
- Market Cap
- FSS 6.8B
- IONS 6.8B
- IPO Year
- FSS N/A
- IONS 1991
- Fundamental
- Price
- FSS $107.01
- IONS $42.00
- Analyst Decision
- FSS Hold
- IONS Buy
- Analyst Count
- FSS 3
- IONS 16
- Target Price
- FSS $108.00
- IONS $58.25
- AVG Volume (30 Days)
- FSS 578.5K
- IONS 2.0M
- Earning Date
- FSS 07-24-2025
- IONS 07-31-2025
- Dividend Yield
- FSS 0.52%
- IONS N/A
- EPS Growth
- FSS 15.62
- IONS N/A
- EPS
- FSS 3.41
- IONS N/A
- Revenue
- FSS $1,900,400,000.00
- IONS $717,253,000.00
- Revenue This Year
- FSS $11.47
- IONS $9.08
- Revenue Next Year
- FSS $7.08
- IONS $14.72
- P/E Ratio
- FSS $31.59
- IONS N/A
- Revenue Growth
- FSS 7.85
- IONS N/A
- 52 Week Low
- FSS $66.47
- IONS $23.95
- 52 Week High
- FSS $114.40
- IONS $52.34
- Technical
- Relative Strength Index (RSI)
- FSS 56.46
- IONS 63.20
- Support Level
- FSS $106.90
- IONS $41.28
- Resistance Level
- FSS $114.40
- IONS $43.64
- Average True Range (ATR)
- FSS 2.25
- IONS 1.36
- MACD
- FSS -0.43
- IONS -0.06
- Stochastic Oscillator
- FSS 39.23
- IONS 63.77
About FSS Federal Signal Corporation
Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates in the segments of Environmental Solutions Group and the Safety and Security Systems Group. The Environmental Solutions group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group offers comprehensive systems and products such as campus and community alerting, emergency vehicles, first responder interoperable communications, and others. The company generates a majority of its revenue from the Environmental Solutions Group segment.
About IONS Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis received FDA approval in 2024 for Tryngolza for a rare high-triglyceride syndrome, marking its first independent launch.